Approval · Notice of Compliance 5380 · 1994
TELEBRIX 38: Notice of Compliance 5380
Issued November 2, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5380
- Date
- November 2, 1994
- Company
- Mallinckrodt MedicalAthlone, WM, Ireland
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Radiopaque contrast medium
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TELEBRIX 38 | 02131684 | Cancelled Post Market |
Medicinal ingredients
- IOXITALAMATE MEGLUMINE 513 MG per ML
- IOXITALAMATE SODIUM 255 MG per ML